Literature DB >> 5342269

Syphilitic temporal arteritis.

J L Smith, C W Israel, R E Harner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5342269     DOI: 10.1001/archopht.1967.00980030286005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  8 in total

1.  Demonstration of treponeme-like forms in cases of treated and untreated late syphilis and of treated early syphilis.

Authors:  N S Rice; E M Dunlop; B R Jones; M J Hare; A J King; P Rodin; A Mushin; A E Wilkinson
Journal:  Br J Vener Dis       Date:  1970-02

2.  Infarction in the optic nerve.

Authors:  C Ellenberger; M G Netsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-12       Impact factor: 10.154

3.  The diagnostic value of temporal-artery biopsy.

Authors:  D E Townes; F C Blodi
Journal:  Trans Am Ophthalmol Soc       Date:  1968

4.  Late ocular syphilis: transfer of infection from man to experimental animals.

Authors:  J L Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1969

Review 5.  Controversies regarding giant cell (temporal, cranial) arteritis.

Authors:  J Eshaghian
Journal:  Doc Ophthalmol       Date:  1979-09-17       Impact factor: 2.379

6.  Immunofluorescent staining of Treponema pallidum and Treponema pertenue in tissues fixed by formalin and embedded in paraffin wax.

Authors:  H T Al-Samarrai; W G Henderson
Journal:  Br J Vener Dis       Date:  1977-02

7.  Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome.

Authors:  Kayo Ishii; Takahiro Mizuuchi; Yusuke Yamamoto; Hiroaki Mori; Mayu Tago; Eri Kato; Haeru Hayashi; Koichiro Tahara; Tetsuji Sawada
Journal:  Intern Med       Date:  2020-02-26       Impact factor: 1.271

Review 8.  Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases.

Authors:  Fabian Lötscher; Roxana Pop; Pascal Seitz; Mike Recher; Luca Seitz
Journal:  Curr Rheumatol Rep       Date:  2022-08-03       Impact factor: 4.686

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.